NEW YORK (GenomeWeb News) — Clinical Data last week said that its board has authorized a 3-for-2 stock split, which will be effected in the form of a stock dividend.

 

On Oct. 1, stockholders of record as on Sept. 24 will receive one new share for every two shares they hold, the company said in a statement.